Table 1. Baseline characteristics of all participants (n=10).
| Variable | Value |
|---|---|
| Age, yr | 61 (57–71.5) |
| Male sex | 6 (60) |
| T2DM duration, yr | 15 (11.5–18.3) |
| Glycosylated hemoglobin, % | 8.0 (7.6–8.3) |
| Glycoalbumin, % | 19.8 (17.0–27.3) |
| Metformin, mg/day | 1,000 (850–1,700) |
| Glimepiride, mg/day | 2.5 (1.8–6) |
| HTN | 6 (60) |
| BMI, kg/m2 | 25.8 (23.3–28.2) |
| SBP, mm Hg | 139 (127.8–151.8) |
| DBP, mm Hg | 87 (85–89) |
| FPG, mg/dL | 161.5 (147.3–207.3) |
| Insulin, μIU/mL | 5.7 (4.1–9.6) |
| C-peptide, ng/mL | 1.9 (1.5–3.2) |
| Total cholesterol, mg/dL | 158 (133.8–189.3) |
| Triglyceride, mg/dL | 105 (85.5–153) |
| HDL, mg/dL | 48 (38.5–62.8) |
| LDL, mg/dL | 96 (80.3–124.3) |
| CRP, mg/dL | 0.05 (0.03–0.06) |
| Carbohydrate, g/day | 225.9 (217.6–279.9) |
| Fat, g/day | 45.0 (26.2–52.3) |
| Fiber, g/day | 25.6 (19.5–32.8) |
Values are presented as median (interquartile range) or number (%).
T2DM, type 2 diabetes mellitus; HTN, hypertension; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL, high density lipoprotein; LDL, low density lipoprotein; CRP, C-reactive protein.